SCHEMBL5464191

SCHEMBL5464191

Cc1nc(N)nc2c1C(=O)CC(c1ccccc1OCCN1CCN(C)CC1)C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.53
HSP90AB1 P08238 2/20 0.53
ALDH1A1 P00352 7/20 0.40
LMNA P02545 3/20 0.40
MAPK1 P28482 3/20 0.40
HTT P42858 3/20 0.40
NOS3 P29474 3/20 0.40
NOS1 P29475 3/20 0.40
NOS2 P35228 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
USP2 O75604 2/20 0.40
TSHR P16473 3/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 3/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
POLB P06746 1/20 0.38
PRKDC P78527 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5464905 0.86 HSP90AA1 (0.48) HSP90AA1HSP90AB1ALDH1A1LMNAMAPK1
SCHEMBL5463191 0.83 HSP90AA1 (0.62) HSP90AA1HSP90AB1ALDH1A1LMNAMAPK1
SCHEMBL5477710 0.82 HSP90AA1 (0.43) HSP90AA1HSP90AB1ALDH1A1LMNAMAPK1
SCHEMBL1779006 0.80 HSP90AA1 (0.66) HSP90AA1HSP90AB1ALDH1A1LMNAMAPK1
SCHEMBL4618394 0.77 HSP90AA1 (0.60) HSP90AA1HSP90AB1ALDH1A1LMNAMAPK1
SCHEMBL5470543 0.77 HSP90AA1 (0.62) HSP90AA1HSP90AB1ALDH1A1LMNAMAPK1
SCHEMBL4620866 0.77 HSP90AA1 (0.65) HSP90AA1HSP90AB1ALDH1A1LMNAMAPK1
SCHEMBL5471332 0.77 HSP90AA1 (0.62) HSP90AA1HSP90AB1ALDH1A1LMNAMAPK1
SCHEMBL5458097 0.76 HSP90AA1 (0.57) HSP90AA1HSP90AB1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL14582379 0.75 HSP90AA1 (0.60) HSP90AA1HSP90AB1ALDH1A1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027150-A1 2-Amino-quinazolin-5-ones TK1, TK2, SLC1A5 HSP90AA1 3373/4885HSP90AB1 3036/4885ALDH1A1 1718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.